People who have previously been treated for a type of bowel cancer that has spread to other parts of their body will now have another treatment option in England.
DNA errors in the cell’s energy ‘factories’ increases the chances of survival for people with bowel cancer, according to a new study.
Temporary disruption to the screening programme over the last year must not become a permanent setback in efforts to save more lives from cancer.
A new and less invasive treatment developed by Cancer Research UK researchers is safer than standard major surgery for early-stage rectal cancer.
The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.
A drug combination for people with a rare type of bowel cancer has received an initial rejection from the National Institute for Health and Care Excellence.
Researchers in Cambridge have pioneered the development of an innovative affinity maturation technique to generate high-affinity antibody against Arginase 2.
Grand Challenge researchers have found that a common type of bacteria found in our guts could contribute to bowel cancer.
Scientists have a developed a new technique to decipher how millions of cells are communicating with each other in miniature tumours grown in the lab.
Scientists in Wales have received £514,000 from Cancer Research UK to develop a new test using Salmonella which aims to detect bowel cancer at an early stage.